Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice

Life Sciences

Volumn 74, Issue 25, 2004, Pages 3075-3084

  Aoki, Kazutaka ^a   Taniguchi, Hideki ^b   Ito, Yuzuru ^b   Satoh, Shinobu ^c   Nakamura, Satoru ^b   Muramatsu, Kenichi ^b   Yamashita, Ryo ^b   Ito, Satoshi ^a   Mori, Yasumichi ^b   Sekihara, Hisahiko ^b  

^a YOKOSUKA KYOSAI HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c CHIGASAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

db db mouse; Dehydroepiandrosterone; Glucose production

Indexed keywords

BICARBONATE; FRUCTOSE; INSULIN; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; GLUCONEOGENESIS; GLUCOSE METABOLISM; HETEROZYGOSITY; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; LIVER CELL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; STATISTICAL ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELLS, CULTURED; DEHYDROEPIANDROSTERONE; DIABETES MELLITUS; GLUCONEOGENESIS; GLUCOSE; HEPATOCYTES; HETEROZYGOTE; HYPERINSULINISM; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE;

EID: 11144356264     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.031     Document Type: Article

References (30)

1. Aoki K., Homma M., Hirano T., Oka K., Satoh S., Mukasa K., Ito S., Sekihara H. mRNA and enzymatic activity of hepatic 11 beta-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice. Life Sciences. 69(21):2001;2543-2549.
2. Aoki K., Kikuchi T., Mukasa K., Itoh S., Nakajima A., Satoh S., Okamura A., Sekihara H. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: Comparison with troglitazone. Endocr J. 47(6):2000;799-804.
3. Aoki K., Saito T., Satoh S., Mukasa K., Kaneshiro M., Kawasaki S., Okamura A., Sekihara H. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/KsJ-db/db mice: Comparison with troglitazone. Diabetes. 48(8):1999;1579-1585.
4. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharriere O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEA study to a sociobiomedical issue. Proc Natl Acad Sci USA. 11(97 (8)):2000;4279-4284.
5. Berry M.N., Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 43(3):1969;506-520.
6. Cersosimo E., Garlick P., Ferretti J. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes. Diabetes. 50(9):2001;2087-2093.
7. Cleary M.P. The anti obesity effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med. 196(1):1991;8-16.
8. Coleman D.L., Leiter E.H., Schwizer R.W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes. 31(9):1982;830-833.
9. Coleman D.L., Schwizer R.W., Leiter E.H. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and aged normal mice. Diabetes. 33(1):1984;26-32.
10. Davies G.F., Khandelwal R.L., Roesler W.J. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism. Biochim. Biophys. Acta. 1451(1):1999;122-131.
11. Dillon J.S., Yaney G.C., Zhou Y., Voilley N., Bowen S., Chipkin S., Bliss C.R., Schultz V., Schuit F.C., Prentki M., Waxman D.J., Corkey B.E. Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes. 49(12):2000;2012-2020.
12. Gunnarsson R. Function of the pancreatic B-Cell during the development of hyperglycemia in mice homozygous for the mutations "diabetes" (db) and "misty"(m). Diabetologia. 11(5):1975;431-438.
13. Ishizawa M., Ishizuka T., Kajita K., Miura A., Kanoh Y., Kimura M., Yasuda K. Dehydroepiandrosterone (DHEA) stimulates glucose uptake in rat adipocytes: activation of phospholipase D. Comp Biochem Physiol B Biochem Mol Biol. 130(3):2001;359-364.
14. Ishizuka T., Kajita K., Miura A., Ishizawa M., Kanoh Y., Itaya S., Kimura M., Muto N., Mune T., Morita H., Yasuda K. DHEA improves glucose uptake via activations of protein kinase C and phosphatidylinositol 3-kinase. Am J Physiol. 276(1 Pt 1):1999;E196-E204.
15. McIntosh M.K., Berdanier C.D. Antiobesity effects of dehydroepiandrosterone are mediated by futile substrate cycling in hepatocytes of BHE/cbd Rats. J Nutr. 121(12):1991;2037-2043.
16. Joseph S.E., Heaton N., Potter D., Pernet A., Umpleby M.A., Amiel S.A. Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes. 49(3):2000;450-456.
17. Kawano H., Yasue H., Kitagawa A., Hirai N., Yoshida T., Soejima H., Miyamoto S., Nakano M., Ogawa H. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab. 88(7):2003;3190-3195.
18. Kimura M., Tanaka S., Yamada Y., Kikuchi Y., Yamakawa T., Sekihara H. Dehydroepiandrosterone decreases serum TNF-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology. 139(7):1998;3249-3253.
19. Lasco A., Frisina N., Morabito N., Gaudio A., Morini E., Trifiletti A., Basile G., Nicita-Mauro V., Cucinotta D. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur J Endocrinol. 145(4):2001;457-461.
20. Mukasa K., Kaneshiro M., Aoki K., Okamura J., Saito T., Satoh S., Sekihara H. Dehydroepiandrosterone (DHEA) ameliorates the insulin sensitivity in older rats. J. Steroid Biochem. Mol. Biol. 67(4):1998;355-358.
21. Osawa E., Nakajima A., Yoshida S., Omura M., Nagase H., Ueno N., Wada K., Matsuhashi N., Ochiai M., Nakagama H., Sekihara H. Chemoprevention of precursors to colon cancer by dehydroepiandrosterone (DHEA). Life Sciences. 19(70 (22)):2002;2623-2630.
22. Pilkis S.J., Granner D.K. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol. 54:1992;885-909.
23. Roth G.S., Lane M.A., Ingram D.K., Mattison J.A., Elahi D., Tobin J.D., Muller D., Metter E.J. Biomarkers of caloric restriction may predict longevity in humans. Science. 2(297 (5582)):2002;811.
24. Rous S. Effect of insulin on incorporation of 14C-labeled pyruvates and bicarbonate into blood glucose of fasted mice. Am J Physiol. 235(1):1978;E22-E26.
25. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell Biol. 13:1976;29-83.
26. Shikama H., Ui M. Metabolic background for glucose tolerance. Mechanism for epinephrine-induced impairment. Am J Physiol. 229:1975;E955-E967.
27. Shiroyama K., Moriwaki K., Yuge O. The direct effect of dopamine on glucose release from primary cultured rat hepatocytes. In Vivo. 12(5):1998;527-529.
28. Ueno T., Ozaki S. Analysis of interaction between insulin binding and insulin effect on primary culture of normal and db/db mouse hepatocytes. Gastroenterol Jpn. 25(3):1990;369-375.
29. van Vollenhoven R.F. Dehydroepiandrosterone in the treatment of systemic lupus erythematosus. Rheumatology (Oxford). 39(8):2000;929-930.
30. Yamaguchi Y., Tanaka S., Yamakawa T., Kimura M., Ukawa K., Yamada Y., Ishihara M., Sekihara H. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinemia. Clin Endocrinol (Oxf). 49(3):1998;377-383.